Herpes Simplex Virus Treatment Market to Grow via CRISPR Gene Editing
The Herpes Simplex Virus Treatment Market encompasses a range of antiviral therapies designed to manage both HSV-1 and HSV-2 infections through oral, topical, and emerging gene-editing approaches. Traditional products such as acyclovir, valacyclovir, and famciclovir remain the mainstay, offering proven efficacy in reducing viral replication, minimi